Filing Details
- Accession Number:
- 0000899243-22-001650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 21:11:24
- Reporting Period:
- 2022-01-11
- Accepted Time:
- 2022-01-11 21:11:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1827087 | Vigil Neuroscience Inc. | VIGL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1826967 | Stefan Vitorovic | Vigil Neuroscience, Inc. 1 Broadway, 7Th Floor, Suite 07-300 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-11 | 3,333,245 | $0.00 | 3,333,245 | No | 4 | C | Indirect | By Vida Ventures III, L.P. |
Common Stock | Acquisiton | 2022-01-11 | 7,684 | $0.00 | 7,684 | No | 4 | C | Indirect | By Vida Ventures III-A, L.P. |
Common Stock | Acquisiton | 2022-01-11 | 1,671,148 | $14.00 | 5,004,393 | No | 4 | P | Indirect | By Vida Ventures III, L.P. |
Common Stock | Acquisiton | 2022-01-11 | 3,852 | $14.00 | 11,536 | No | 4 | P | Indirect | By Vida Ventures III-A, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Vida Ventures III, L.P. |
No | 4 | C | Indirect | By Vida Ventures III-A, L.P. |
No | 4 | P | Indirect | By Vida Ventures III, L.P. |
No | 4 | P | Indirect | By Vida Ventures III-A, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2022-01-11 | 9,243,756 | $0.00 | 3,333,245 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2022-01-11 | 21,310 | $0.00 | 7,684 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
- The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any.
- The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any.
- On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
- On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.